Viking Therapeutics (VKTX) – Major News
-
Viking Therapeutics (VKTX) Tops Q1 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 1c
-
Viking Therapeutics (VKTX) Misses Q3 EPS by 1c
-
Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
-
Viking Therapeutics (VKTX) Misses Q1 EPS by 1c
-
Viking Therapeutics (VKTX) Misses Q4 EPS by 3c
-
Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
-
Viking Therapeutics (VKTX) Misses Q1 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 3c
-
Viking Therapeutics (VKTX) Tops Q3 EPS by 4c
-
Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
-
Viking Therapeutics (VKTX) Misses Q1 EPS by 2c
-
Viking Therapeutics (VKTX) Reports In-Line Q4 EPS
-
Viking Therapeutics (VKTX) Tops Q3 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q2 EPS by 1c
-
Viking Therapeutics (VKTX) Misses Q1 EPS by 1c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 3c
-
Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08
-
Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q1 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 3c
-
Viking Therapeutics (VKTX) Tops Q3 EPS by 1c
-
Viking Therapeutics (VKTX) Says Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol Achieved its Primary Endpoint
-
Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q1 EPS by 3c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 4c
-
Viking Therapeutics (VKTX) Misses Q3 EPS by 2c
-
Viking Therapeutics (VKTX) Misses Q2 EPS by 1c
-
Viking Therapeutics (VKTX) Misses Q1 EPS by 6c
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 2c
-
Viking Therapeutics (VKTX) Tops Q3 EPS by 1c
-
Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share
-
Viking Therapeutics (VKTX) Misses Q4 EPS by 12c
-
Viking Therapeutics (VKTX) Posts Q2 Loss of $1.07/Share
-
Viking Therapeutics (VKTX) IPO Opens Modestly Higher
Back to VKTX Stock Lookup